News/ News/ R&D Biogen bolsters pipeline again with Alectos deal Phil Taylor Alectos Therapeutics, Biogen, neurology, Parkinson's disease, partnering 0 Comment Biogen has added a preclinical-stage drug candidate for Parkinson’s disease via a $722.5 million licensing agreement with Alectos Share X Biogen bolsters pipeline again with Alectos deal https://pharmaphorum.com/news/biogen-bolsters-pipeline-again-with-alectos-deal/
Alectos Therapeutics, Biogen, neurology, Parkinson's disease, partnering
0 Comment
